Encapsulated Neoplasm — Trials

Encapsulated Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

60 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06959641	XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer	recruiting	Phase 2	33	Jochen LorchOTHER	1	Jun 26, 2026	clinicaltrials
NCT06440850	Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation	recruiting	Phase 2	21	City of Hope Medical CenterOTHER	1	Feb 2, 2026	clinicaltrials
NCT05668962	Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC	recruiting	Phase 2	30	Massachusetts General HospitalOTHER	1	Dec 12, 2024	clinicaltrials

Data updated 22 days agoSource updated Jun 26, 2026source: clinicaltrials